Format

Send to

Choose Destination
See comment in PubMed Commons below
Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1051-67. Epub 2006 Apr 4.

Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.

Author information

1
Academic Neurology Unit, Section of Neuroscience, E Floor, Medical School, Beech Hill Road, Sheffield S10 2RX, UK.

Abstract

The cause(s) of amyotrophic lateral sclerosis (ALS) is not fully understood in the vast majority of cases and the mechanisms involved in motor neuron degeneration are multi-factorial and complex. There is substantial evidence to support the hypothesis that oxidative stress is one mechanism by which motor neuron death occurs. This theory becomes more persuasive with the discovery that mutation of the anti-oxidant enzyme, superoxide dismutase 1 (SOD1), causes disease in a significant minority of cases. However, the precise mechanism(s) by which mutant SOD1 leads to motor neuron degeneration have not been defined with certainty, and trials of anti-oxidant therapies have been disappointing. Here, we review the evidence implicating oxidative stress in ALS pathogenesis, discuss how oxidative stress may affect and be affected by other proposed mechanisms of neurodegeneration, and review the trials of various anti-oxidants as potential therapies for ALS.

PMID:
16713195
DOI:
10.1016/j.bbadis.2006.03.008
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center